Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


An Open Label, Single Center Study to Assess the Pharmacokinetics, Safety and Tolerability of Multiple Administrations of 30 mg PMI-150 (Intranasal Ketamine) in Healthy Adult Volunteers


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00519987

Organisation Name: Javelin Pharmaceuticals

Overal Status: Completed

Start Date: June 2007

Last Update: January 10, 2008

Lead Sponsor: Javelin Pharmaceuticals

Brief Summary: This is an open label, single-center study of the pharmacokinetic and safety profile of repeat doses of PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers.

Conditions:
  • Healthy


Total execution time in seconds: 0.14779305458069